Intellia Therapeutics, Inc.
NASDAQ-GM: NTLA
,USD
-0,40 (3,07%)↓ today
Price at Feb 20, 4:00:01 PM EST • Market Closed
Loading...
Details
Valuations
Market Cap
Market Cap
Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles
1,46B
PEG Ratio
PEG Ratio
Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles
0,08
Trailing P/E Ratio
Trailing P/E Ratio
Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles
-2,41
Forward P/E Ratio
Forward P/E Ratio
Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles
-3,51
Financial Performance
Revenue (TTM)
57,53M
Operating Cash Flow (TTM)
-410,65M
Net Profit Margin (TTM)
Net Profit Margin (TTM)
Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"
0,00%
Diluted EPS (TTM)
Diluted EPS (TTM)
Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles
-4,25
Cash
Total Cash (MRQ)
511,04M
Operating Free Cash Flow (TTM)
-410,65M
Levered Free Cash Flow (TTM)
-223,88M
Total Cash per Share (MRQ)
4,41
Advanced Valuations
Enterprise Value
1,05B
Enterprise Value to EBITDA
-2,24
Price-to-Sales (TTM)
Price-to-Sales (TTM)
Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles
25,45
Price-to-Book (MRQ)
1,96
Balance Sheet
Total Debt (MRQ)
97,97M
Debt to Equity (MRQ)
13,09
Current Ratio (MRQ)
6,21
Book Value per Share (MRQ)
6,46
Detailed Financials
Revenue Growth (MRQ)
51,30%
Earnings Growth (YOY)
51,27%
Return on Equity (TTM)
-52,11%
Gross Profit Margin
Gross Profit Margin
Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"
0,00%
Share Information
Shares Outstanding
115,79M
Shares Float
110,02M
Beta
2,11
52-Week Range
5,90 - 28,25
Trading & Ownership
Institutional Ownership
87,14%
Insider Ownership
4,86%
Short Interest
43,89%
Average 90-Day Volume
5,60M
Dividends
Payout Ratio
0,00%
Forward Dividend Yield
0,00%
Ex. Dividend Date
Unknown
Dividend Date
Unknown
Indicators
Founder-Operated
No
Founder-operated companies generally perform better.
CEO
John M. Leonard
Founders
Jennifer Doudna, Luciano Marraffini, Derrick J. Rossi
Industry Safety Score
1/5
Biotechnology
Net Profitability Score
2/5
As compared to these industry peers.
Loading...
Indicators
Founder-Operated
No
Founder-operated companies generally perform better.
CEO
John M. Leonard
Founders
Jennifer Doudna, Luciano Marraffini, Derrick J. Rossi
Industry Safety Score
1/5
Biotechnology
Net Profitability Score
2/5
As compared to these industry peers.
Details
Valuations
Market Cap
Market Cap
Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles
1,46B
PEG Ratio
PEG Ratio
Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles
0,08
Trailing P/E Ratio
Trailing P/E Ratio
Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles
-2,41
Forward P/E Ratio
Forward P/E Ratio
Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles
-3,51
Financial Performance
Revenue (TTM)
57,53M
Operating Cash Flow (TTM)
-410,65M
Net Profit Margin (TTM)
Net Profit Margin (TTM)
Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"
0,00%
Diluted EPS (TTM)
Diluted EPS (TTM)
Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles
-4,25
Cash
Total Cash (MRQ)
511,04M
Operating Free Cash Flow (TTM)
-410,65M
Levered Free Cash Flow (TTM)
-223,88M
Total Cash per Share (MRQ)
4,41
Advanced Valuations
Enterprise Value
1,05B
Enterprise Value to EBITDA
-2,24
Price-to-Sales (TTM)
Price-to-Sales (TTM)
Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles
25,45
Price-to-Book (MRQ)
1,96
Balance Sheet
Total Debt (MRQ)
97,97M
Debt to Equity (MRQ)
13,09
Current Ratio (MRQ)
6,21
Book Value per Share (MRQ)
6,46
Detailed Financials
Revenue Growth (MRQ)
51,30%
Earnings Growth (YOY)
51,27%
Return on Equity (TTM)
-52,11%
Gross Profit Margin
Gross Profit Margin
Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"
0,00%
Share Information
Shares Outstanding
115,79M
Shares Float
110,02M
Beta
2,11
52-Week Range
5,90 - 28,25
Trading & Ownership
Institutional Ownership
87,14%
Insider Ownership
4,86%
Short Interest
43,89%
Average 90-Day Volume
5,60M
Dividends
Payout Ratio
0,00%
Forward Dividend Yield
0,00%
Ex. Dividend Date
Unknown
Dividend Date
Unknown